RASSF8 and cervical cancer: In addition, RASSF8 was downregulated in lymph node metastasis–positive samples as compared with metastasis-negative samples, such as in cervical cancer (NCBI/GEO/GSE26511; p = 0.036; Supplementary Fig. 1A) and prostate tumor (NCBI/GEO/GSE6919; Supplementary Fig. 1B).